Cell-free Assays (IC50/Ki) for MYCi975
| Key Target | IC50 (Cell-free) | Description | Reference |
|---|---|---|---|
| No published data available. | |||
Cell-based Assay (IC50) for MYCi975
| Cell Type | IC50 (Cell-based) | Description | Reference |
|---|---|---|---|
| panel of 14 breast cancer cell lines | 2.49 to 7.73 µM | MTT assay | Download PDF |
| HBEC | 0.6 μM | ATP luminescence assay | PMC12148720 |
Check the
MYCi975
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Jump to
- MYCi975 Mechanism of Action: MYC Inhibition in Prostate Cancer Cells Research
- MYCi975 Working Concentration | Cell Culture | Treatment
- MYCi975 Solubility in DMSO
- MYCi975 Stock Solution
- MYCi975 Storage
- MYCi975 Stability
- MYCi975 Combination Database
- MYCi975 Molecular Weight
- MYCi975 SMILES
- MYCi975 CAS Number
- MYCi975 Chemical Structure (2D and 3D)
- MYCi975 Cayman (39622)? Try a better option.
- MYCi975 Axonmedchem (Axon 3229)? Try a better option.
- MYCi975 Santa Cruz (sc-507277)? Try a better option.
- MYCi975 Abmole (M11420)? Try a better option.
- MYCi975 Sigma (AMBH95E07DAA)? Try a better option.
- MYCi975 SDS｜MSDS